↓ Skip to main content

The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study

Overview of attention for article published in Frontiers in immunology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study
Published in
Frontiers in immunology, September 2022
DOI 10.3389/fimmu.2022.975246
Pubmed ID
Authors

Jia Hu, Di Huang, Yanrong Wang, Donghui Li, Xuejiao Yang, Yan Fu, Nan Du, Yan Zhao, Xiaosong Li, Junxun Ma, Yi Hu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 25%
Unspecified 1 13%
Student > Doctoral Student 1 13%
Lecturer > Senior Lecturer 1 13%
Student > Ph. D. Student 1 13%
Other 1 13%
Unknown 1 13%
Readers by discipline Count As %
Medicine and Dentistry 2 25%
Immunology and Microbiology 2 25%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Unspecified 1 13%
Nursing and Health Professions 1 13%
Other 0 0%
Unknown 1 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2022.
All research outputs
#17,866,085
of 26,170,906 outputs
Outputs from Frontiers in immunology
#20,993
of 33,018 outputs
Outputs of similar age
#256,755
of 436,460 outputs
Outputs of similar age from Frontiers in immunology
#1,281
of 2,082 outputs
Altmetric has tracked 26,170,906 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,018 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,460 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2,082 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.